Posted August 27, 2015: by Bill Sardi

    Today’s news headlines once again attribute recent declines in coronary heart disease mortality to statin drugs and modern treatments like arterial stents.

    Citing a report in the European Heart Journal, The Daily Mail, a British publication, mistakenly claims Great Britain has “one of the best records in Europe” with 184 deaths per 100,000 people for coronary heart disease — a dramatic 46.9% decline over the past 10 years. [European Heart Journal Aug 25, 2015; Daily Mail UK Aug 26, 2015] Yet the chart below reveals Great Britain (United Kingdom) isn’t even in the top 10 countries with the lowest death rate for coronary artery disease.

    Read the whole post »

  • Newly Approved Injectable Cholesterol Drug Is A Cardiologist’s Dream And It Just May, Unlike Cholesterol-Lowering Statin Drugs, Save Lives This Time

    Posted July 27, 2015: by Bill Sardi

    It’s a cardiologist’s dream come true.  A newly approved $1200/monthly-injectable drug that dramatically reduces circulating cholesterol levels may become the first $100-200 billion medicine.

    That would dwarf the record $9 billion annual sales for Lipitor, the statin cholesterol-lowering drug that was the best selling drug of all time until its patent recently expired.  And to add value to the equation, this newly FDA-approved drug may be the first cholesterol-lowering medication to actually save lives, but for different reasons than advertised.

    Read the whole post »

  • What To Do After Placement Of Stents In Coronary Arteries

    Posted April 15, 2015: by Bill Sardi

    So you’ve had your heart attack or heart scare and cardiologists have relieved your unremitting chest pain by placement of wire props called stents in any of your four coronary arteries that supply the heart with oxygenated blood.

    By now you’ve probably been placed on blood thinners and cholesterol-lowering drugs. But don’t fall into the trap of believing modern medicine’s false paradigm that cholesterol accumulation in your coronary arteries resulted in arterial narrowing and eventually a blood clot that caused your heart attack.

    Before you become cholesterol-phobic it might be time to learn what really caused a blood clot to form in a coronary artery.

    Read the whole post »

  • Those Acid Stomach Heartburn Symptoms May Foretell A Heart Attack

    Posted April 4, 2015: by Bill Sardi

    The Connection Between Stress, Heartburn, Poor Bile Flow, Elevated Lipoprotein(a), Vitamin C Deficiency And Heart Attack

    For a long time now I have listened to numerous heart attack victims, including a brother and four other male friends, explain symptoms that occurred when they experienced their crushing-chest-pain heart attack. In all these cases it sounded like they were having a gall bladder attack, not a heart attack.

    Their stories were common: chest pain after a meal, strong acid reflux sometimes relieved by antacids and sometimes a history of prior gallstone problems or gall bladder removal.

    Read the whole post »

  • A New Blood Test Predicts Impending Heart Attacks But Will It Save Lives?

    Posted January 11, 2014: by Bill Sardi

    Over a year ago I reported on a blood test that can predict an impending heart attack days prior to its occurrence.  The test measured the number of circulating cells sloughed off from the inside of arteries that can block coronary arteries that supply oxygen to the heart.  But I asked then, “what to do next?”

    The test needed to be refined and validated, which is what Scripps Institute researchers announced recently in the journal of Physical Biology.

    But precisely what would cardiologists do to prevent the onset of a heart attack if the test indicates a heart attack is imminent?

    Most likely they will employ drugs that reduce coagulation (clotting) of the blood but the number of these microparticles must be reduced to address the problem directly.

    Read the whole post »

  • American Heart Association Calls For 35 Million More Americans To Take Liver-Toxic Statin Drugs Despite Lack Of Conclusive Evidence Of Benefit

    Posted November 13, 2013: by Bill Sardi

    Nov. 12, 2013- Out with monitoring cholesterol numbers.  In what is being called a “tectonic shift in the way doctors treat high cholesterol,” the American Heart Association unexpectedly announced new guidelines today for prescribing statins drugs.

    Without admission that older guidelines were a misdirection, the new guidelines abandon the idea of lowering “bad” LDL cholesterol to below 100 and re-set that number at 190.  No mention is made about raising HDL “good” cholesterol, which cardiologists also once embraced till a major study had to be halted when elevation of HDL cholesterol resulted in increased deaths.

    Cardiologists hope to get it right this time saying subjects who don’t fit the newly established guidelines should be encouraged to implement lifestyle changes such as smoking cessation along with dietary and exercise regimens.

    Read the whole post »

  • High-Risk Cardiovascular Disease Patients Fare No Better Whether They Diligently Adhere To Medication Regimens Or Not

    Posted August 16, 2013: by Bill Sardi

    In the looming era of the Affordable Care Act, where all medical technologies must be validated scientifically or billings for medicines, devices or services will not be fully reimbursed, modern medicine is struggling to substantiate its many therapies.

    An example is a recent study published in The American Journal of Medicine. Researchers attempted to blame the inability to demonstrate reduction in cardiovascular death over a period of 4 years on poor patient compliance.

    Less than half of these high-risk patients (48.2%) fully adhered to medication regimens.

    Read the whole post »


    Posted August 15, 2013: by Bill Sardi

    RADIO BROADCAST KLAV-1230AM, Las Vegas, NV, August 15,2013

    An Open Letter To American Medicine


    Dear Doctor:

    If there is any doctor listening out there…

    I read your best medical journals, as I’m sure you do.

    I know the difference between statistical and clinical improvements.

    I know that the central focus of modern medicine in the past four decades, cholesterol reduction with statin drugs, has not significantly lowered mortality among high-risk or healthy adults (if you don’t believe what I just said, then check the bulletin just issued in the Journal of the American Medical Association). Harvard Dr. John Abramson, author of Overdosed America, has also documented that fact among healthy adults. The alarming part of the newly issued AMA bulletin is that the assumed benefits of lowering mortality among high-risk statin drug users has also been a false assumption.

    Read the whole post »

  • Affordable Care Act Forces Cardiology To Reveal Its Cholesterol Shell Game

    Posted August 12, 2013: by Bill Sardi

    Comment: The newly released report (click link to review), published in the Journal of the American Medical Association (JAMA), concedes that statin drugs have now been relegated as secondary intervention in the prevention of heart disease.  What now serves as primary prevention in its place, according to the JAMA report, are control of “lifestyle factors” such as smoking cessation, dietary measures, and limitation of alcohol intake).

    This is a nice way of saying the major direction of western medicine in the last forty years has been flawed, even corrupt.  Unfortunately, the only penalty for being wrong has been experienced by those who took statin drugs in good faith, paid the price with their lives, believing their well-trained physicians were guiding them in the right direction. That wasn’t true, and cardiologists knew this for a long time prior to the published report below.

    Read the whole post »

  • Something Huge Is Going On In The Cholesterol World

    Posted August 5, 2013: by Bill Sardi

    Something huge is going on in the cholesterol world. Those lipoproteins we have been taught to be phobic over – LDL (low density “bad” cholesterol), total cholesterol and triglycerides, as well as HDL cholesterol (high density “good” lipoproteins), believed to clog arteries and induce heart attacks, are losing scientific ground as true measures of your risk for a mortal heart attack. Another lipoprotein that was cast aside decades ago is gaining attention.

    That lipoprotein is called lipoprotein(a). Readers may recall it is the cholesterol particle that was temporarily made famous by vitamin C researchers Drs. Linus Pauling and Matthias. Since their research in the 1990s lipoprotein(a) has been largely shunned and ignored.

    Before I go on to write about lipoprotein(a), I am forced to address the shortcomings of the cholesterol theory of heart disease. It takes a strong amount of evidence to convince anyone, especially gullible statin drug users, that cholesterol is a mistaken direction in modern medicine.

    Read the whole post »

« Previous Entries Next Entries »